["{\n\"step_by_step_thinking\": \"The question is about tremelimumab improving survival of mesothelioma patients. The provided documents are about methotrexate treatment for malignant pleural mesothelioma, intracranial metastases from mesothelioma, and electrophysiological study on mexiletine. There is no information about tremelimumab in these documents. Therefore, it's not possible to conclude whether tremelimumab improves survival of mesothelioma patients based on this information.\",\n\"answer_choice\": \"B\""]